LR

LARIMAR THERAPEUTICS INC

LRMR·517125100·US·Common Stock·Healthcare - Biotechnology-Activist

LRMR (LARIMAR THERAPEUTICS INC) is held by 95 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($16.9M), MILLENNIUM MANAGEMENT LLC ($16.3M), DRIEHAUS CAPITAL MANAGEMENT LLC ($13.2M). Net institutional sentiment: Mixed.

95
Holders
Avg rating(21 Elite)
$152.8M
Total Value
64% (100)
Fund Consensus
60 buying - 34 selling
LRSmart Money Verdict
View all
Held by 95 funds
21 elite
Who's Trading
InsiderHEHamilton Thomas EdwardBuy $167KJul 6, 2026
ActivistBOBlue Owl Capital Holdings LP10.0%May 14, 2026
ActivistMillennium Management LLCMillennium Management LLC3.5%Apr 30, 2026
ActivistDPDeerfield Private Design Fund III, L.P.10.3%Mar 2, 2026
InsiderFEFlynn James EBuy $5.4MFeb 27, 2026
InsiderFEFlynn James EBuy $5.4MFeb 27, 2026
InsiderFEFlynn James EBuy $4.2MFeb 27, 2026
InsiderFEFlynn James EBuy $10.0MFeb 27, 2026
InsiderHEHamilton Thomas EdwardBuy $500KFeb 27, 2026
InsiderTETHOMAS FRANK EBuy $25KFeb 27, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.8M(+1.9%)$16.9M0.0%+9.81%
29
Decreased
3.6M(-30.4%)$16.3M0.0%+28.51%
0
Increased
2.9M(+448.0%)$13.2M0.1%-23.62%
45
New
2.9M$12.9M0.0%-22.32%
39
Increased
1.6M(+15.9%)$7M0.0%+15.35%
32
Decreased
1.5M(-52.0%)$6.8M0.1%+26.63%
0
Increased
1.4M(+74.9%)$6.3M0.0%-7.35%
41
Increased
1.1M(+1.4%)$5M0.0%-26.33%
27
Decreased
1M(-28.3%)$4.7M0.0%+23.49%
0
New
933,464$4.2M0.0%-22.32%
37
Decreased
911,326(-0.1%)$4.1M0.0%-25.17%
0
New
847,644$3.8M0.0%-22.32%
37
Increased
817,517(+62.8%)$3.7M0.0%+8.24%
39
Increased
798,462(+143.8%)$3.6M0.0%-11.33%
43
Increased
739,942(+148.9%)$3.3M0.0%-12.86%
43
Increased
674,915(+541.7%)$3M0.0%-15.11%
43
Increased
635,024(+52.9%)$2.9M0.0%+7.09%
37
Decreased
617,211(-33.5%)$2.8M0.0%-5.26%
0
Increased
575,624(+31.6%)$2.6M0.0%-0.33%
33
Decreased
554,007(-18.4%)$2.5M0.0%+19.73%
0

Showing 1-20 of 100

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used